Pharmaceutical companies are focusing on patient and site centric features.
Cost savings- ability to reduce study drop-out rates;
save time and money for sites, patients and sponsors.
Virtual visits/platform improve protocol compliance and study retention.
Increase geographic reach and diversity of patient populations.
BYOD model- app works on any device; no provisioning of devices.
Video, audio, messaging interpretation available (183 languages)
SCRS Global Impact Partner
Site members have access/training to become virtually certified.
Pharma can continue to use their preferred site networks
- Real-time reporting of AEs/ more accurate data
- Hybrid model assures continued PI oversight